Geode Capital Management’s Quince Therapeutics QNCX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$655K Buy
396,982
+1,272
+0.3% +$2.1K ﹤0.01% 3469
2025
Q1
$526K Buy
395,710
+19,778
+5% +$26.3K ﹤0.01% 3522
2024
Q4
$703K Buy
375,932
+36,807
+11% +$68.8K ﹤0.01% 3491
2024
Q3
$263K Buy
339,125
+66,170
+24% +$51.4K ﹤0.01% 3815
2024
Q2
$205K Buy
272,955
+6,059
+2% +$4.55K ﹤0.01% 3900
2024
Q1
$283K Buy
266,896
+5,158
+2% +$5.47K ﹤0.01% 3817
2023
Q4
$275K Buy
261,738
+42,135
+19% +$44.3K ﹤0.01% 3836
2023
Q3
$246K Buy
219,603
+32,441
+17% +$36.3K ﹤0.01% 3900
2023
Q2
$282K Buy
187,162
+50,076
+37% +$75.4K ﹤0.01% 3893
2023
Q1
$214K Hold
137,086
﹤0.01% 4015
2022
Q4
$87K Sell
137,086
-9,128
-6% -$5.79K ﹤0.01% 4444
2022
Q3
$194K Hold
146,214
﹤0.01% 4229
2022
Q2
$324K Sell
146,214
-136,897
-48% -$303K ﹤0.01% 3992
2022
Q1
$1.75M Sell
283,111
-26,490
-9% -$164K ﹤0.01% 3320
2021
Q4
$3.91M Sell
309,601
-20,246
-6% -$255K ﹤0.01% 3027
2021
Q3
$30.2M Buy
329,847
+28,135
+9% +$2.58M ﹤0.01% 1691
2021
Q2
$16M Buy
301,712
+42,405
+16% +$2.25M ﹤0.01% 2122
2021
Q1
$9.34M Buy
259,307
+23,359
+10% +$842K ﹤0.01% 2409
2020
Q4
$6.55M Sell
235,948
-5,302
-2% -$147K ﹤0.01% 2442
2020
Q3
$12.1M Buy
241,250
+71,124
+42% +$3.56M ﹤0.01% 1843
2020
Q2
$7.88M Buy
170,126
+35,747
+27% +$1.65M ﹤0.01% 2075
2020
Q1
$6.13M Buy
134,379
+27,538
+26% +$1.26M ﹤0.01% 2021
2019
Q4
$6M Buy
106,841
+50,336
+89% +$2.83M ﹤0.01% 2337
2019
Q3
$1.41M Buy
56,505
+2,529
+5% +$63K ﹤0.01% 3106
2019
Q2
$2.29M Buy
+53,976
New +$2.29M ﹤0.01% 2858